The 'Fat Mass and Obesity Related' (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the fat mass and obesity related (FTO) gene were the first common variants discovered to be associated with body mass index and body fatness. This review summarises what has been later discovered about the biology of FTO drawing together information from both human and animal studies. Subsequent work showed that the 'at risk' alleles of these SNPs are associated with greater food intake and increased hunger/lowered satiety, but are not associated with altered resting energy expenditure or low physical activity in humans. FTO is an FE (II) and 2-oxoglutarate dependent DNA/RNA methylase. Contrasting the impact of the SNPs on energy balance in humans, knocking out or reducing activity of the Fto gene in the mouse resulted in lowered adiposity, elevated energy expenditure with no impact on food intake (but the impact on expenditure is disputed). In contrast, overexpression of the gene in mice led to elevated food intake and adiposity, with no impact on expenditure. In rodents, the Fto gene is widely expressed in the brain including hypothalamic nuclei linked to food intake regulation. Since its activity is 2-oxoglutarate dependent it could potentially act as a sensor of citrate acid cycle flux, but this function has been dismissed, and instead it has been suggested to be much more likely to act as an amino acid sensor, linking circulating AAs to the mammalian target of rapamycin complex 1. This may be fundamental to its role in development but the link to obesity is less clear. It has been recently suggested that although the obesity related SNPs reside in the first intron of FTO, they may not only impact FTO but mediate their obesity effects via nearby genes (notably RPGRIP1L and IRX3).

Original languageEnglish
Pages (from-to)73-91
Number of pages19
JournalCurrent Obesity Reports
Volume4
Issue number1
Early online date12 Feb 2015
DOIs
Publication statusPublished - Mar 2015

Fingerprint

Obesity
Fats
Single Nucleotide Polymorphism
Eating
Genes
Adiposity
Health Expenditures
Introns
Energy Metabolism
tRNA Methyltransferases
Appetite Regulation
Hunger
Citric Acid
Rodentia
Body Mass Index
Alleles
Amino Acids
Acids
DNA
Brain

Keywords

  • FTO
  • GWAS
  • BMI
  • Body composition
  • Adiposity
  • Fatness
  • Obesity
  • Food intake
  • Energy expenditure
  • Physical activity
  • 2-oxoglutarate
  • Demethylation
  • DNA
  • RNA
  • Leptin
  • Ghrelin
  • Hypothalamus
  • Amino acid sensor
  • mTOR
  • Protein intake
  • Macronutreient intake
  • IRX3
  • RPGRIP1L
  • FTM

Cite this

The 'Fat Mass and Obesity Related' (FTO) gene : Mechanisms of Impact on Obesity and Energy Balance. / Speakman, John R.

In: Current Obesity Reports, Vol. 4, No. 1, 03.2015, p. 73-91.

Research output: Contribution to journalArticle

@article{baf47c91b2804b78acbd42fa254ce869,
title = "The 'Fat Mass and Obesity Related' (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance",
abstract = "A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the fat mass and obesity related (FTO) gene were the first common variants discovered to be associated with body mass index and body fatness. This review summarises what has been later discovered about the biology of FTO drawing together information from both human and animal studies. Subsequent work showed that the 'at risk' alleles of these SNPs are associated with greater food intake and increased hunger/lowered satiety, but are not associated with altered resting energy expenditure or low physical activity in humans. FTO is an FE (II) and 2-oxoglutarate dependent DNA/RNA methylase. Contrasting the impact of the SNPs on energy balance in humans, knocking out or reducing activity of the Fto gene in the mouse resulted in lowered adiposity, elevated energy expenditure with no impact on food intake (but the impact on expenditure is disputed). In contrast, overexpression of the gene in mice led to elevated food intake and adiposity, with no impact on expenditure. In rodents, the Fto gene is widely expressed in the brain including hypothalamic nuclei linked to food intake regulation. Since its activity is 2-oxoglutarate dependent it could potentially act as a sensor of citrate acid cycle flux, but this function has been dismissed, and instead it has been suggested to be much more likely to act as an amino acid sensor, linking circulating AAs to the mammalian target of rapamycin complex 1. This may be fundamental to its role in development but the link to obesity is less clear. It has been recently suggested that although the obesity related SNPs reside in the first intron of FTO, they may not only impact FTO but mediate their obesity effects via nearby genes (notably RPGRIP1L and IRX3).",
keywords = "FTO, GWAS, BMI, Body composition, Adiposity, Fatness, Obesity, Food intake, Energy expenditure, Physical activity, 2-oxoglutarate, Demethylation, DNA, RNA, Leptin, Ghrelin, Hypothalamus, Amino acid sensor, mTOR, Protein intake , Macronutreient intake, IRX3, RPGRIP1L, FTM",
author = "Speakman, {John R}",
year = "2015",
month = "3",
doi = "10.1007/s13679-015-0143-1",
language = "English",
volume = "4",
pages = "73--91",
journal = "Current Obesity Reports",
issn = "2162-4968",
publisher = "Springer US",
number = "1",

}

TY - JOUR

T1 - The 'Fat Mass and Obesity Related' (FTO) gene

T2 - Mechanisms of Impact on Obesity and Energy Balance

AU - Speakman, John R

PY - 2015/3

Y1 - 2015/3

N2 - A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the fat mass and obesity related (FTO) gene were the first common variants discovered to be associated with body mass index and body fatness. This review summarises what has been later discovered about the biology of FTO drawing together information from both human and animal studies. Subsequent work showed that the 'at risk' alleles of these SNPs are associated with greater food intake and increased hunger/lowered satiety, but are not associated with altered resting energy expenditure or low physical activity in humans. FTO is an FE (II) and 2-oxoglutarate dependent DNA/RNA methylase. Contrasting the impact of the SNPs on energy balance in humans, knocking out or reducing activity of the Fto gene in the mouse resulted in lowered adiposity, elevated energy expenditure with no impact on food intake (but the impact on expenditure is disputed). In contrast, overexpression of the gene in mice led to elevated food intake and adiposity, with no impact on expenditure. In rodents, the Fto gene is widely expressed in the brain including hypothalamic nuclei linked to food intake regulation. Since its activity is 2-oxoglutarate dependent it could potentially act as a sensor of citrate acid cycle flux, but this function has been dismissed, and instead it has been suggested to be much more likely to act as an amino acid sensor, linking circulating AAs to the mammalian target of rapamycin complex 1. This may be fundamental to its role in development but the link to obesity is less clear. It has been recently suggested that although the obesity related SNPs reside in the first intron of FTO, they may not only impact FTO but mediate their obesity effects via nearby genes (notably RPGRIP1L and IRX3).

AB - A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the fat mass and obesity related (FTO) gene were the first common variants discovered to be associated with body mass index and body fatness. This review summarises what has been later discovered about the biology of FTO drawing together information from both human and animal studies. Subsequent work showed that the 'at risk' alleles of these SNPs are associated with greater food intake and increased hunger/lowered satiety, but are not associated with altered resting energy expenditure or low physical activity in humans. FTO is an FE (II) and 2-oxoglutarate dependent DNA/RNA methylase. Contrasting the impact of the SNPs on energy balance in humans, knocking out or reducing activity of the Fto gene in the mouse resulted in lowered adiposity, elevated energy expenditure with no impact on food intake (but the impact on expenditure is disputed). In contrast, overexpression of the gene in mice led to elevated food intake and adiposity, with no impact on expenditure. In rodents, the Fto gene is widely expressed in the brain including hypothalamic nuclei linked to food intake regulation. Since its activity is 2-oxoglutarate dependent it could potentially act as a sensor of citrate acid cycle flux, but this function has been dismissed, and instead it has been suggested to be much more likely to act as an amino acid sensor, linking circulating AAs to the mammalian target of rapamycin complex 1. This may be fundamental to its role in development but the link to obesity is less clear. It has been recently suggested that although the obesity related SNPs reside in the first intron of FTO, they may not only impact FTO but mediate their obesity effects via nearby genes (notably RPGRIP1L and IRX3).

KW - FTO

KW - GWAS

KW - BMI

KW - Body composition

KW - Adiposity

KW - Fatness

KW - Obesity

KW - Food intake

KW - Energy expenditure

KW - Physical activity

KW - 2-oxoglutarate

KW - Demethylation

KW - DNA

KW - RNA

KW - Leptin

KW - Ghrelin

KW - Hypothalamus

KW - Amino acid sensor

KW - mTOR

KW - Protein intake

KW - Macronutreient intake

KW - IRX3

KW - RPGRIP1L

KW - FTM

U2 - 10.1007/s13679-015-0143-1

DO - 10.1007/s13679-015-0143-1

M3 - Article

C2 - 26627093

VL - 4

SP - 73

EP - 91

JO - Current Obesity Reports

JF - Current Obesity Reports

SN - 2162-4968

IS - 1

ER -